The facts
Revenue was US$5.143 billion a year earlier. Organic revenue growth, which excludes specified currency and business-scope effects, was 6.2%. [1]
Net income was US$615 million, compared with US$446 million. Diluted earnings rose to US$1.36 a share from US$0.98. [1][2]
Adjusted quarterly earnings were US$1.34 a share, against US$1.07. Adjusted figures exclude specified items and differ from GAAP earnings. [1][2]
The company now expects approximately 4% organic revenue growth for 2026, compared with its previous 3–4% range, RTTNews reported. [2]
Sources
References support the numbered facts above. Source checks: 29 Oct 2026, 13:55 UTC.
- GE HealthCare reports third quarter 2026 financial results
GE HealthCare · Primary source · 28 Oct 2026
Issuer’s quarterly results and definitions read. Comparative guidance ranges are supported by the opened RTTNews report.
- GE HealthCare shares rise 7% on higher Q3 results, FY26 outlook upgrade
RTTNews · Reporting · 28 Oct 2026
Independent financial reporting. Its transient share-price move is not repeated without a complete market-quote basis.